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Abstract 
Parkinson’s disease is the second most common neurodegenerative disorder, affecting 
nearly 1 million people in the US and it is predicted that the number will keep increasing. 
Parkinson’s disease is difficult to diagnose due to its similarity with other diseases that 
share the parkinsonian symptoms and the subjectivity of its assessment, thus 
increasing the probabilities of misdiagnosis. Therefore, it is relevant to develop 
diagnostic tools that are quantitatively based and monitoring tools to improve the 
patient’s quality of life. Computer-based assessment systems have shown to be 
successful in this field through diverse approaches that can be classified into two main 
categories: sensor-based and computer vision-based systems. In this thesis, the 
implementation of a computer vision system to detect Parkinson’s disease is explored. 
As Parkinson’s diseases has characteristic motor symptoms, and gait is mainly affected, 
a computer vision system is proposed to analyze the gait features to classify subjects 
with Parkinson’s disease. Using Microsoft’s Kinect sensor and Azure Kinect sensor, the 
position of body joints in a 3D space was obtained and angles between those were 
calculated. The standard deviation of 7 different angles over time was calculated for 
each and used as features in a support vector machine with the purpose of classifying 
Parkinson’s disease patients versus controls. Moreover, challenges and future 
perspectives for the implementation of computer-vision systems as supportive 
diagnostic tools for Parkinson’s disease are discussed. 
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Introduction 
In the last decade, medicine has evolved exponentially; multiple treatments and 
diagnostic tools have been developed for many areas. However, the early diagnosis 
and treatment of neurodegenerative diseases has eluded this rapid evolution in 
medicine. The complexity and roots of these diseases play an important role in the 
difficulty to diagnose and treat them. One disease in particular, Parkinson’s disease, 
has a vast impact on patients’ quality of life. Parkinson’s disease affects more than 10 
million people worldwide, nearly 1 million people in the US, and it is expected that the 
number will keep growing (Marras et al. 2018). Parkinson’s disease is a progressive 
parkinsonism due to the loss of dopaminergic neurons in the substantia nigra of the 
midbrain without an identifiable cause, and has bradykinesia, resting tremor, rigidity, 
postural reflex impairment, shuffling gait and imbalance as motor symptoms (Jellinger 
1991; Jankovic and Tolosa 2015; Papadakis 2019). The treatment of Parkinson’s 
disease in early stages with cabergoline, a dopamine receptor agonist, has shown a 
lower risk and delay of onset motor complications (Rinne et al. 1998). As the treatment 
of Parkinson’s disease at early stages has shown a lower risk and delay of onset motor 
complications it is relevant to be able to recognize subtle motor problems as early as 
possible in the development of the disease. On the other hand, it is estimated that when 
motor symptoms appear, already 50% of all dopamine receptors have disappeared 
(Marsden 1990; Ross et al. 2004). Therefore, several premotor symptoms have been 
proposed for the early diagnosis of Parkinson’s disease (Tolosa et al. 2007, 2009; 
Iranzo 2011; Lang 2011); however, the most studied premotor symptoms like olfactory 
loss, REM sleeping disorder, constipation and mood changes are not specific enough to 
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be used as stand-alone biomarkers to diagnose Parkinson’s disease (Tinelli et al. 
2016). As the non-motor motor symptoms are not specific enough to be used as stand-
alone indicators of the development of Parkinson’s disease, and concurrently a powerful 
revolution in computer science has taken place in the last decades, the implementation 
of computer systems as supportive diagnostic tools has become a growing research 
area.  
Moreover, an important advantage of the computer-based systems compared to the 
traditional scales for Parkinson’s disease diagnosis is their objectivity, as the analysis 
performed is quantitative contrasted to the qualitative assessment of traditional scales 
that could be confounded by observer bias. As beforementioned, while nonmotor 
symptoms are present in all patients, these symptoms are mainly used as supportive 
criteria for the diagnosis, as they are not definitive indicators of Parkinson’s disease. 
Therefore, it is relevant to focus on the motor symptoms for the implementation of 
computer-based systems in the diagnosis and monitoring of Parkinson’s disease.  
In this research project, a computationally inexpensive pipeline and programs are 
developed in order to classify subjects as Parkinson’s disease patients or controls. 
Microsoft Kinect Azure and Microsoft Kinect v2 are used to obtain the 3D position of the 
joints, and angles are calculated from those. Posteriorly, a support vector machine is 
implemented to classify Parkinson’s patients versus controls using the standard 
deviation from the previously calculated angles as features. As one of the key motor 
symptoms of Parkinson’s patients is a rigid gait, it would be expected that Parkinson’s 
patients’ angles would have a lower standard deviation compared to controls. 
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The research question proposed is whether the standard deviation of the angles can be 
used as an effective feature for classifying the subjects.  
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Chapter I: Background 
Pathology and epidemiology of Parkinson’s disease 
Parkinson’s disease is the second most common neurodegenerative disorder (Reich 
and Savitt 2018) as it affects more than 10 million people worldwide and nearly 1 million 
people in the US (Marras et al. 2018). It is important to recognize the difference 
between parkinsonism and Parkinson’s disease as they have different recommend 
treatments and disease courses. Parkinsonism refers to a clinical syndrome of 
bradykinesia, resting tremor, rigidity, postural reflex impairment, shuffling gait and 
imbalance, while Parkinson’s disease refers to a type of progressive parkinsonism due 
to the loss of dopaminergic neurons in the substantia nigra of the midbrain without an 
identifiable cause (Jellinger 1991). The 3 most common disorders that lead to 
Parkinsonism are Parkinson’s disease, Progressive Supranuclear Palsy (PSP) and 
Multiple System Atrophy (MSA). The most common cause of parkinsonism is 
Parkinson’s disease; however, a differential diagnosis is required to differentiate 
between the multiple possible causes for parkinsonism (Reich and Savitt 2018). 
The current medical procedure to assess Parkinson’s disease is to perform a medical 
differential diagnosis, in which the medical practitioner uses several exclusion criteria to 
determine if the patient has Parkinson’s disease (Papadakis 2019). Several 
characteristic symptoms of Parkinson’s disease can be attributed to other disorders, 
such as rigidity and bradykinesia are found in Huntington disease patients, and 
myoclonic jerking in Creutzfeldt-Jakob disease patients (Papadakis 2019). However, the 
presence of symptoms not characteristic of Parkinson’s disease is used as the 
exclusion criteria that indicate the possibility of another disorder to afflict the patient. For 
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example, Creutzfeldt-Jakob disease may present symptoms of parkinsonism, but the 
progression is rapid; as well as, Huntington disease could be mistaken for parkinsonism 
unless the family history and accompanying dementia are recognized (Papadakis 
2019). The Movement Disorder Society (MDS) proposes clinical diagnostic criteria for 
Parkinson’s disease, based on 4 main steps (Goldman and Postuma 2014). The first 
one is to establish the presence of parkinsonism through visual analysis to recognize 
bradykinesia and either rest tremor or rigidity. The second step is to establish the 
absence of absolute exclusion criteria to ensure that the parkinsonism is not caused by 
another disease. The third step is to identify supportive criteria that are characteristic of 
Parkinson’s disease and not usually found in other unrelated courses of parkinsonism; 
the most important is a “clear and dramatic beneficial response to dopaminergic 
therapy” (Postuma et al. 2015). The fourth and last step is to search for red flags that 
might throw uncertainty on the diagnosis; for example, the rapid progression of gait 
impairment that would require the use of a wheelchair in the first 5 years of symptoms 
onset (Goldman and Postuma 2014). Once the medical practitioner has diagnosed 
Parkinson’s disease, the next step is to assign a value in a standardized scale. The two 
main scales are the Hoehn Yahr and the Unified Parkinson’s Disease Rating Scale 
(UPDRS) (Goetz et al. 2004). The original Hoehn Yahr scale is divided into 5 stages 
(Hoehn and Yahr 2011), while the UPDRS has rating scale out of 100. While the Hoehn 
Yahr has been criticized due to its focus mainly on the movement complications; the 
original version remains widely used nowadays due to its simplicity, and recommended 
by the MDS task force when clinical testing has not been performed (Goetz et al. 2004). 
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Table 1 presents the original Hoehn Yahr scale for rating the progression of Parkinson’s 
disease; which was used in this research project. 
Stages Description 
Stage 1  Unilateral involvement only. 
Stage 2 Bilateral involvement without impairment of balance. 
Stage 3 Mild to moderate bilateral involvement, some postural instability but 
physically independent. 
Stage 4 Severe disability, still able to walk and to stand unassisted. 
Stage 5 Confinement to bed or wheelchair unless aided 
Table 1. Original Hoehn Yahr scale for Parkinson’s disease progression rating scale. 
However, in spite of the diagnostic criteria proposed by the MDS, it remains a challenge 
to have an accurate diagnosis for Parkinson’s disease, as currently the misdiagnose 
rate is approximately 18% of the cases (Schrag et al. 2002; Wermuth et al. 2012). 
Moreover, in a systematic review of 20 studies from 1988 and 2014, it was found that 
during those 25 years, the overall validity of clinical diagnosis for Parkinson’s disease 
did not improve significantly. Additionally, the accuracy of clinical diagnosis performed 
by movement disorders experts on an initial assessment was found to be at 79.6% 
(Rizzo et al. 2016). 
The neuropathology of Parkinsonian disorders divides them into two main categories 
based on biochemical and structural abnormalities in tau protein and α-synuclein, which 
are two major proteins in the central nervous system (Jankovic and Tolosa 2015). 
Parkinson’s disease has been traditionally classified as a synucleinopathy (affects α-
synuclein); however, the discovery of common genetic variants in the tau gene (MAPT) 
in genome-wide association studies of idiopathic Parkinson’s disease shows evidence 
7 
 
of a link between Parkinson’s disease and tau protein (Jankovic and Tolosa 2015). 
Parkinson’s disease neuropathology is characterized by degeneration of the 
nigrostriatal dopaminergic neurons in the substantia nigra (Jankovic and Tolosa 2015). 
At this point, synuclein pathology has spread to the midbrain to include basal forebrain 
and cortical structures (Jankovic and Tolosa 2015).  The degeneration of the 
nigrostriatal dopaminergic neurons results in striatal dopamine-deficiency syndrome 
that, in turn, is responsible for the classical motor symptoms in Parkinson’s disease 
(Jellinger 1991). Moreover, idiopathic Parkinson’s disease is characterized by the 
presence of Lewis Bodies – which are abnormal protein aggregate that develop inside 
nerve cells (Michael-Titus et al. 2010) – in the nigrostriatal neurons and loss of 
neuromelanin pigmentation in the substantia nigra and locus ceruleus (Jankovic and 
Tolosa 2015). 
While there is no specific cause for the degeneration of said dopaminergic neurons in 
the substantia nigra, there are several risk factors that have been directly associated 
with Parkinson’s disease. These risk factors include increasing age, male gender, white 
race, drinking well water, a diet rich in animal fat, milk and iron, obesity, midlife 
constipation, rapid-eye-movement sleep disorder, physical and emotional stress, family 
history, rural residence, pesticides, farming, teaching and health care work, and 
exposure to metals like iron and manganese (Kasten et al. 2007). Furthermore,  
Parkinson’s disease has been found to have 24 different associated genes (Fahn et al. 
2011). These include SNCA, MAPT, Parkin, PINK1, LRRK2 and many other gene 
mutations. Pathology in patients can vary due to the different gene mutations and even 
within single families. Gene mutation can follow a mendelian inheritance as autosomal 
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dominant such as SNCA and LRRK2 or autosomal recessive such as Parkin, Pink1 and 
DJ-1 (Fahn et al. 2011; Jankovic and Tolosa 2015). 
As before mentioned, Parkinson’s disease affects more than 10 million people 
worldwide and nearly 1 million people in the US (Marras et al. 2018). Moreover, it has 
an estimated crude incidence that ranges from 5 to 20 cases per 100,000 population 
per year (Rosati et al. 1980; Rajput et al. 1984; Twelves et al. 2003). Incidence is 
defined as the number of new cases of a disease occurring in a specific population 
during a given period. As incidence is not affected by survival after diagnosis or by the 
migration of affected individuals, it is the best measure of disease frequency (Jankovic 
and Tolosa 2015). On the other hand, prevalence reflects both incidence and survival, 
as it is defined as the total number of individuals in a population who have the disease 
at a specific point in time. The estimated prevalence of Parkinson’s disease in Europe is 
between 100 and 200 cases per 100,000 population (Kasten et al. 2007) and in North 
America 572 per 100,000 (Marras et al. 2018). Moreover, comparison of prevalence 
studies worldwide indicate that Parkinson’s disease might be more common in the 
developed world (Kasten et al. 2007); however, due to the methodological differences, 
such as age distribution, the results might be confounded. Nevertheless, it is clear that 
the prevalence rises exponentially after the age of 50 (Kasten et al. 2007). 
Sensor-based assessments 
Since gait is a coordinated action between the nervous system and the musculoskeletal 
system, it makes gait a reliable indicator of neurodegenerative diseases (Ortells et al. 
2018); therefore, the interest of implementing computer systems in the analysis of gait 
patterns to aid in the diagnosis of neurodegenerative diseases. An approach taken to 
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develop computer-based systems to aid in the diagnosis and monitoring of Parkinson’s 
disease is the sensor-based assessment. Several systems have been developed with 
successful results, with different approaches between older and recent systems. Earlier 
versions involve more invasive wearable sensors strapped to upper or lower extremities 
(Keijsers et al. 2006; Bächlin et al. 2009; Pansera et al. 2009; Patel et al. 2009; Cancela 
et al. 2010).  Contrastingly, more recent developments have diminished the 
invasiveness of the sensors and implemented a pair of sensors attached to the ankles 
or shoes (Moore et al. 2008; Barth et al. 2011; Raccagni et al. 2018). Moreover, some 
have focused on the detection of gait freezing, which is a common cause of falls in 
advanced Parkinson’s, in order to monitor the patient and prevent falls that can later 
lead to lethal ailments, such as internal bleeding (Moore et al. 2008; Bächlin et al. 
2009). Most of the sensor-based approaches use accelerometers, gyroscopes, EKG 
measurements or a combination of these in order to track and analyze a variety of 
movement-related features and find recognizable differences in the patterns (Keijsers et 
al. 2006; Rissanen et al. 2008; Bächlin et al. 2009; Pansera et al. 2009; Patel et al. 
2009; Cancela et al. 2010; LeMoyne et al. 2010, 2010). The tracking of movement 
patterns other than gait has also shown promising results (Keijsers et al. 2006; 
Rissanen et al. 2008; LeMoyne et al. 2010; Eskofier et al. 2016). Furthermore, the 
implementation of deep learning algorithms – a subset of machine learning in artificial 
intelligence – in sensor-based movement assessment has shown improved results 
compared to machine learning algorithms previously used (Eskofier et al. 2016). It is 
important to highlight that while many of the systems cited are specialized in detecting 
or monitoring Parkinson’s disease movement abnormalities, research has also been 
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performed to analyze the differences between gait patterns of other causes of 
parkinsonism that can be misidentified as Parkinson’s disease (Raccagni et al. 2018), 
such as multiple system atrophy (MSA) and progressive supranuclear palsy (PSP). This 
is relevant as Parkinson’s disease has been shown to be misdiagnosed in 
approximately 18% of the cases (Schrag et al. 2002; Wermuth et al. 2012). 
Computer-based vision systems assessments 
Computer vision systems can gain high-level understanding from digital images and 
videos. The implementation of computer vision systems to track gait patterns is a field 
that has grown significantly in the last decade as gait is unique for every person and the 
visual assessment can be automated with a computer. In addition, computer vision 
analysis is a non-invasive, non-intrusive measurement since the subject does not need 
to behave in a certain way (Lee et al. 2014). Moreover, cameras and video processing 
software have improved enough to track and analyze biomechanical data. For these 
reasons, the implementation of computer vision systems as a diagnostic and treatment 
supportive tool has gained interest in the scientific and medical community. Some 
systems tend to need specialized environments and computationally expensive 
processes (Green et al. 2000; Lee et al. 2008; Cho et al. 2009), while less sophisticated 
vision devices, such as Microsoft Kinect, have shown accurate measurements on a 
variety of gait parameters (Rocha et al. 2015; Xu et al. 2015) and some other devices 
have used computationally inexpensive calculations (Khan et al. 2013).  
Most computer-based vision assessments use consumer standard cameras to record 
the movements of Parkinson’s disease patients.  The main differences appear in the 
image analysis methods and algorithm to determine if the subject has Parkinson’s 
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disease. Dr. Kahn and his team in Motion Cue Analysis for Parkinsonian Gait 
Recognition (Khan et al. 2013) provide a clear vision-based algorithm for parkinsonian 
gait recognition. First, a recording of the subject is made, then a background subtraction 
is applied to differentiate the pixels from the subject and the background. Posteriorly, a 
noise-filtering technique is applied and then the silhouette is isolated. Afterward, a 
skeleton is made by applying a model fitting to distinguish the head, torso and leg 
segments. Finally, motion cues are extracted and compared to an imaginary perfect gait 
to determine if the subject presents normal or parkinsonian gait. 
Gait analysis methods  
Different analysis techniques are used for the gait parameters. The most prevalent are 
Linear discriminant Analysis (LDA) (Green et al. 2000; Cho et al. 2009) and Support-
Vector Machine (SVM) (Bauckhage et al. 2009; Khan et al. 2013). Linear discriminant 
analysis is a method commonly used in machine learning for the classification of one or 
more groups in a sample by using features related to the groups. Support Vector 
Machine works similarly to LDA with the main difference that the SVM focuses on the 
points that are difficult to classify giving more weight to those. Meanwhile LDA assumes 
that data is normally distributed. SVM finds a hyperplane that divides the sample into 
groups by optimizing the distance between the data points that are close to the 
boundary. Both approaches are less computationally expensive compared to neural 
networks and other deep learning techniques. Moreover, a more recent approach used 
a cloud platform-based web service to perform a classification between normal and 
abnormal gait (Nieto-Hidalgo et al. 2018).  A cloud platform is convenient as it 
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eliminates the need for on-site data processing, and it optimizes the need for 
computational resources. 
Frontal versus sagittal 
Another relevant difference within the published research is the use of frontal versus 
sagittal image analysis. In frontal analysis, the patient walks straight to and away from 
the camera, while in sagittal analysis the subject walks on a straight line perpendicular 
to the vision field of the camera. Frontal analysis is advantageous due to the reduction 
of space for the patient to walk. However, as shown by Nieto-Hidalgo and his team, the 
sagittal approach proved to be more accurate (Nieto-Hidalgo et al. 2018). 
Kinect implementation 
In previous research, Microsoft’s Kinect has been implemented for Parkinson’s disease 
detection. Rocha and her team were able to develop a system based on Kinect v2 for 
Parkinson’s Disease Assessment (Rocha et al. 2015). The data evaluated showed that 
96% of gait parameters were statistically significant to make a distinction between 
controls and Parkinson’s subjects. Therefore, they concluded that the gait analysis 
provided by Kinect v2 was valuable as a supportive method for assessing Parkinson’s 
disease in a clinical setting. It is important to recognize the advantages provided by the 
implementation of the Kinect, which are the computational inexpensive processing and 
the reduction of the constraints in the environment while reducing noise in the image 
processing at the same time.  
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Chapter II: Materials and Methods 
The subject’s gait was recorded using a Microsoft Kinect v2 and Microsoft Kinect Azure 
while the subject walked unaided over an unobstructed 10 meters walkway. The Kinects 
were placed perpendicular to the subject’s path (sagittal view or side view). Recordings 
by the beforementioned devices were limited to joint tracking and calculation between 
the angles of the specific joints. Two programs were developed, as each one of the 
sensors uses a different language. The program used for Microsoft’s Kinect for Xbox 
One was a modified version provided by Guillermo Hernandez from a previous project; 
while the program used for Microsoft Azure Kinect was a modified version of Microsoft’s 
Azure Kinect Samples, specifically a modified version of the simple_sample project 
(Microsoft 2019). The 3D position of the body joints was provided by the sensors and in 
the same programs, the angles between the joints were calculated and recorded over 
time. The joints tracked by Kinect Azure and Kinect v2 are shown in figures 1 and 2 
respectively. The angles of the joints were calculated using the following formula, where 
a, b, c are the 3D vectors of the corresponding joints for the angles. 
𝐴 = 𝑎 − 𝑏 
𝐵 = 𝑐 − 𝑏 
180 − acos (
𝐴
|𝐴|
∗
𝐵
|𝐵|
) ∗
180
𝜋
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Figure 2. Retrieved from:(Microsoft 2018)  
In this research project, seven different angles were calculated, as shown in table 1.  
Figure 1. Body joints tracked by Kinect Azure. Retrieved 
from: (Microsoft 2019b) 
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Angle name Joints 
Right knee angle Right ankle, Right knee, Right hip 
Inner torso angle Pelvis, Spine Navel, Spine chest 
Wide torso angle  Neck, Spine navel, Pelvis 
Right elbow angle Right shoulder, Right elbow, Right wrist 
Neck angle Head, Neck, Spine chest 
Stride angle Pelvis, Right ankle, Left Ankle  
Right arm swing angle  Right shoulder, pelvis, right wrist 
Table 2. Angles and their corresponding joints used in the calculations 
Parkinson’s patients were recruited from Clinica Parkinson Puebla, which is a 
Parkinson’s clinic in Puebla, Mexico. Subjects recruited were older than 18 years old 
(male or female) with a Parkinson’s disease diagnosis by a neurologist. 12 previously 
diagnosed Parkinson’s patients accepted to participate in the research. These patients 
were diagnosed by the head neurologist of the Clinica Parkinson Puebla, Dr. Enriquez-
Coronel. Parkinson’s patients ranged in the Hoehn Yahr scale from levels 2 to 4. All 
patients were under treatment; however, none have gone under deep brain stimulation 
surgery (DBS). Deep brain stimulation is a common treatment for Parkinson’s disease 
patients as it shows improvement of all cardinal motor symptoms with sustained long-
term benefits, and significant improvement of quality of life when compared with best 
medical treatment (Groiss et al. 2009). Therefore, patients with DBS would show 
reduced symptoms; thus, being impractical for this experiment. Ages ranged from 52 to 
83 years old. Moreover, 13 controls were recruited from the University of Mississippi 
student, faculty and staff population. Ages ranged from 21 to 55 years old.   
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Hoehn Yahr Scale Male Female 
1 - - 
2 - 3 
3 2 5 
4 - 2 
5 Not able to walk unless aided 
Table 4. Distribution of Parkinson’s patients for the Hoehn Yahr scale. Patients on level 5 were not included as those patients 
cannot walk unless aided. 
1-3 measurements were taken for each Parkinson patient depending on gait difficulties 
of the subject; additionally, 3 measurements for each control were taken to ensure that 
at least one measurement was available for analysis, as sensors failed often to record 
the data resulting in empty files. 
A linear support vector machine (SVM) was implemented in R for the classification of 
Parkinson’s patients versus controls. The angles provided by the first two programs 
were read into the R program, and the standard deviation for each angle per subject 
was calculated. The mean and median of the standard deviations for the angles of 
Parkinson’s patients and controls were calculated and compared to see which angles 
had a larger difference and thus expected to be better classifiers. Afterward, the 
  
Parkinson's Patients Controls 
Male Female Male Female 
Participants 2 10 8 5 
Age range 52-76 62-83 23-55 21-24 
Table 3. Distribution of patients and controls by gender and age range for each group.  
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standard deviations of each angle per patient were fed to the SVM as features for 
classification. 
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Chapter III: Results 
As the Kinect V2 sensor had problems to record the data often resulting in empty files, 
the data obtained from the Kinect V2 sensor was not used in this analysis. All the 
following results are based on the Azure Kinect sensor recordings. 
In order to have a better understanding of what features could work best for the SVM 
the medians and means of each angle for all Parkinson’s patients and controls where 
calculated, as it can be seen in table 5.  
Angle Right 
knee 
angle 
Inner 
torso 
angle 
Wide 
torso 
angle 
Right 
elbow 
angle 
Neck 
angle 
Stride 
angle 
Right arm 
swing 
angle 
Median 
SD of 
PD 
11.60 1.928 2.333 12.59 1.920 9.370 6.539 
Median 
SD of 
controls 
17.68 1.816 2.341 11.77 1.929 12.42 6.577 
Mean 
SD of 
PD 
17.75 1.874 2.535 13.84 1.881 13.30 7.253 
Mean 
SD of 
controls 
11.39 2.012 2.506 14.08 1.749 11.62 7.484 
Table 5. Medians and means of standard deviation per angle for Parkinson’s patients (PD) and controls. 
Posteriorly, the difference for the median and mean of the standard deviation between 
Parkinson’s patients and controls is shown in tables 6 and 7 respectively. 
Angle Right 
knee 
angle 
Inner 
torso 
angle 
Wide 
torso 
angle 
Right 
elbow 
angle 
Neck 
angle 
Stride 
angle 
Right arm 
swing 
angle 
Median SD 6.079 0.1126 0.0076 0.8146 0.0086 3.0555 0.0377 
Table 6. The difference of median standard deviation between PD patients and controls per angle. 
Angle Right 
knee 
angle 
Inner 
torso 
angle 
Wide 
torso 
angle 
Right 
elbow 
angle 
Neck 
angle 
Stride 
angle 
Right arm 
swing 
angle 
Mean SD 6.360 0.1383 0.0294 0.2310 0.1319 1.682 0.2304 
Table 7. The difference of mean standard deviation between PD patients and controls per angle. 
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As seen in the tables, the right knee angle showed the highest difference for both mean 
and median. While the stride angle also showed a high difference in the median, the 
difference was much lower in the mean. This could probably happen due to median 
being less susceptible to outliers compared to the mean. Furthermore, the right elbow 
angle showed a lower difference in the median compared to the previous two angles; 
however, it showed to be a better classifier than the stride angle. The support vector 
machine (SVM) showed better results at classifying the subjects when the standard 
deviation from the right knee angle and the right elbow angle were used as shown in 
figure 3. When the right knee angle and right elbow angle standard deviations were 
used as features for the SVM, it was able to classify the Parkinson’s patients with an 
86% accuracy. Moreover, the SVM was fitted with the right knee angle and stride angle, 
as the stride angle showed a high difference in the median standard deviation between 
Parkinson’s patients and controls. The SVM classification plot is shown in figure 4. 
However, the accuracy for the SVM fitted with right knee angle and stride angle 
standard deviations was lower, achieving an 83.7%, as seen in figure 5. The accuracy 
of the SVM was calculated using the following equation. 
𝑇𝑟𝑢𝑒 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒 + 𝑇𝑟𝑢𝑒 𝑁𝑒𝑔𝑎𝑡𝑖𝑣𝑒
𝑇𝑟𝑢𝑒 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒 + 𝑇𝑟𝑢𝑒 𝑁𝑒𝑔𝑎𝑡𝑖𝑣𝑒 + 𝐹𝑎𝑙𝑠𝑒 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒 + 𝐹𝑎𝑙𝑠𝑒 𝑁𝑒𝑔𝑎𝑡𝑖𝑣𝑒
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Figure 3.  SVM classification plot for right knee angle standard deviation and right elbow angle standard deviation. Blue points 
represent the Parkinson’s patients, red points represent controls. Points in a square represent support points. The solid black line 
represents the decision boundary. Dashed lines represent the upper and lower margin of the decision boundary. 
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Figure 4. SVM classification plot for right knee angle standard deviation and stride angle standard deviation. Blue points represent 
the Parkinson’s patients, red points represent controls. Points in a square represent support points. The solid black line represents 
the decision boundary. Dashed lines represent the upper and lower margin of the decision boundary. 
Furthermore, to see if an improvement in accuracy could be achieved, the same SVM 
was fitted with recordings from Parkinson’s disease patients that were diagnosed with a 
level equal or greater than 3 in the Hoehn Yahr scale. As can be seen in figure 6, the 
accuracy of the SVM to classify the data increased to 90%, by just misclassifying 1 out 
of 9 Parkinson’s patients and the previous 3 controls. 
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Figure 5. SVM classification plot for right knee angle standard deviation and right elbow angle standard deviation with recordings 
only from patients that had a Hoehn Yahr level of ≥3. Blue points represent the Parkinson’s patients, red points represent controls. 
Points in a square represent support points. The solid black line represents the decision boundary. Dashed lines represent the 
upper and lower margin of the decision boundary. 
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Chapter IV: Discussion 
As Parkinson’s disease is the second most common neurodegenerative disorder (Reich 
and Savitt 2018) and it has no identifiable cause, it is a public health concern to find 
more effective methods to diagnose and monitor the disease. As presented in this 
thesis, several different approaches have been taken in order to develop systems that 
can aid doctors in their diagnosis and monitor the disease progression. While in more 
recent developments the size of the sensors has been reduced and the placement has 
been in less uncomfortable areas, the sensor-based assessments remain invasive. 
Computer vision systems show a significant advantage over the sensor-based 
assessment, as these are not invasive and have similar effectiveness in detecting 
parkinsonian gait patterns. Moreover, computer-vision systems can be computationally 
expensive, which can limit their implementation in the clinics, thus the importance of 
developing systems that are less computationally expensive. 
It is interesting that only 3 of the 7 angles measured were significant for the SVM 
classification, and that it was mainly the right knee angle feature that allowed the SVM 
to classify the subjects. While in this thesis the patient population was small, the 
accuracy for classifying the subjects was slightly higher (86% vs ~82%) than the current 
subjective assessment, which currently has a ~18% misdiagnose rate (Schrag et al. 
2002; Wermuth et al. 2012). Furthermore, it is important to notice that when Parkinson’s 
patients’ recordings were limited to patients with level 3 or higher, the accuracy of the 
SVM classification increased to 90%.  
 
24 
 
Challenges 
Despite the promising results from this system, there are some challenges for the 
implementation in a clinic setting. Some patients might feel uncomfortable with a 
camera recording them during their visit to the doctor. Furthermore, a key challenge is 
that most of the systems analyzed in current literature and the one implemented in this 
thesis are efficient at detecting the parkinsonian gait; however, less research has been 
performed in order to differentiate between the diverse causes of parkinsonian gait, as it 
can not only be caused by idiopathic Parkinson’s disease but atypical parkinsonism 
disorders such as MSA and PSP. Moreover, even Parkinson’s disease has been found 
to have 24 different associated genes (Fahn et al. 2011); therefore, further research is 
needed to have a better understanding of the disease; which consequently will allow 
having better diagnostics and treatments.  
A larger and more diverse sample for Parkinson's disease patients and controls would 
be desired to increase and test the accuracy of the SVM classification system; however, 
it is difficult to recruit Parkinson’s disease patients that can walk unaided and show 
enough symptoms to have a Parkinson’s disease diagnosis. 
At the same time, a relevant challenge is that, as before mentioned, the misdiagnose 
rate is ~18%; thus; putting in doubt the validity of the data used to perform the analysis. 
In all the literature analyzed in this thesis; it is assumed that the patients have been 
correctly diagnosed, and, as in this research project, patients are recruited from highly 
experienced neurologists that should have very low misdiagnose rates. 
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Future perspectives 
These challenges should be encouraging to the scientific and medical community to 
continue developing systems that aid medical practitioners in their diagnosis and 
understanding of the disease course, as well as improve life quality for patients. Further 
research needs to be performed to develop more accurate and precise systems. A more 
complete assessment could include a combination of approaches for the diagnosis of 
Parkinson's disease, including genetic profiles and non-motor symptoms. This type of 
future assessment could be very helpful in the analysis of the disease’s course and 
decrease the misdiagnose rate. Furthermore, the implementation of computationally 
inexpensive computer vision systems, such as the one presented in this thesis, in the 
clinical setting could be incredibly helpful as a supportive tool in the diagnosis of 
Parkinson’s disease by adding a quantitative component to the diagnosis as well as, 
with a very large sample, be able to classify the Parkinson’s disease progress into the 5 
main stages of the Hoehn Yahr scale. Moreover, future research could develop systems 
that detect subtle movements imperceptible to some medical practitioners; this could 
lead to opportune treatments to delay the onset of motor symptoms. 
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